Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012030 |
---|---|
Receipt number | R000014061 |
Scientific Title | A Phase II study of pertuzumab+trastuzumab+capecitabine in Patients with taxans and trastuzumab refractory for advanced or recurrent breast cancer |
Date of disclosure of the study information | 2013/10/15 |
Last modified on | 2017/11/30 18:10:03 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/10/14 16:23:26 | ||
2 | Update | 2017/11/30 18:10:03 | UMIN ID1 |